Cargando…
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study
INTRODUCTION: Autologous stem cell transplantation (ASCT) is the standard treatment for younger patients with newly diagnosed multiple myeloma (MM). However, due to restrictive exclusion criteria, more than half of eligible patients are usually excluded from transplant studies. METHODS: This retrosp...
Autores principales: | Wang, Song-Yau, Holzhey, Tanja, Heyn, Simone, Zehrfeld, Thomas, Fricke, Susann, Hoffmann, Franz Albert, Becker, Cornelia, Braunert, Leanthe, Edelmann, Thomas, Paulenz, Inessa, Hitzschke, Marcus, Flade, Franziska, Schwarzer, Andreas, Fenchel, Klaus, Franke, Georg-Nikolaus, Vucinic, Vladan, Jentzsch, Madlen, Schwind, Sebastian, Hell, Saskia, Backhaus, Donata, Lange, Thoralf, Niederwieser, Dietger, Scholz, Markus, Platzbecker, Uwe, Pönisch, Wolfram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314844/ https://www.ncbi.nlm.nih.gov/pubmed/35987926 http://dx.doi.org/10.1007/s00432-022-04184-x |
Ejemplares similares
-
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
por: Brauer, Dominic, et al.
Publicado: (2021) -
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
por: Holzhey, Tanja, et al.
Publicado: (2021) -
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15
por: Hell, Saskia, et al.
Publicado: (2022) -
High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients
por: Jentzsch, Madlen, et al.
Publicado: (2017) -
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
por: Backhaus, Donata, et al.
Publicado: (2022)